ConductScience.org, home

Paper25288

Long-term hypnotic efficacy and safety of triazolam and flurazepam.

Leibowitz M and 1 other. J Clin Pharmacol, 1978. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Long-term hypnotic efficacy and safety of triazolam and flurazepam. Papers, record 25288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25288

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term hypnotic efficacy and safety of triazolam and flurazepam.
PubMed
Journal
J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.94
iCite
Revised in PubMed
2019-08-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leibowitz MM
2Sunshine AA

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
FlurazepamMajor topic
Hypnotics and SedativesMajor topic
TriazolamMajor topic
Adult
Ambulatory Care
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Sleep
Sleep Initiation and Maintenance Disorders
Time Factors

Source PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
36,947,394The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials.Drugs2023https://conductscience.org/library/papers/36947394PubMed
27,998,379Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.J Clin Sleep Med2017https://conductscience.org/library/papers/27998379PubMed
8,573,298An assessment of short-acting hypnotics.Drug Saf1995https://conductscience.org/library/papers/8573298PubMed
6,133,533Approaches in the evaluation of hypnotics: studies with triazolam.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6133533PubMed
6,123,129Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6123129PubMed
6,114,852Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.Drugs1981https://conductscience.org/library/papers/6114852PubMed
6,108,588The effects of flurazepam, lorazepam, and triazolam on sleep and memory.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6108588PubMed
3,942,931Treatment of triazolam dependence with a tapering withdrawal regimen.CMAJ1986https://conductscience.org/library/papers/3942931PubMed
1,971,955Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood.Psychopharmacology (Berl)1990https://conductscience.org/library/papers/1971955PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25288

GET https://conductscience.org/api/papers/v1/25288/authors